Comprehensive Research Associates   Report issue

For profit Phase 4
Founded: Houston TX United States (1992)

Organization Overview

First Clinical Trial
2020
NCT04443608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Comprehensive Research Associates

Active Ingredients

Drugs in Phase 4 Trials (1)

patiromer (veltassa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperkalemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1